Clinical Trials in Brazil / NCT07643597
Recruiting Observational

Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients

NCT07643597 · tracked via the Priya Life Science Brazil tracker
Sponsor
Hospital Las Higueras
Phase
Observational
Started
2026-07-06
Last updated
2026-07-08

Condition(s) studied

Acute Kidney InjuryFluid OverloadFluid Overload in Dialysis PatientsCritical IllnessRenal Replacement Therapy for Acute Kidney Injury in ICU

Study summary

Acute kidney injury (AKI) is common in critically ill patients and is frequently associated with fluid overload, which can worsen clinical outcomes. Continuous renal replacement therapy (CRRT) allows fluid removal through net ultrafiltration (UFNET), but some patients develop hemodynamic instability or signs of poor tissue perfusion during this process.

The purpose of this prospective observational study is to evaluate tolerance to net ultrafiltration in critically ill patients with AKI receiving CRRT. The study will assess clinical, hemodynamic, ultrasound, perfusion, and biochemical parameters before and during fluid removal to identify factors associated with ultrafiltration intolerance.

The investigators hypothesize that alterations in hemodynamic, perfusion, and congestion-related parameters can identify patients at increased risk of ultrafiltration intolerance before the development of overt hypotension. The results may help improve individualized fluid removal strategies and optimize the safety of CRRT in critically ill patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Admission to an Intensive Care Unit * Acute kidney injury according to KDIGO criteria * Prescription of continuous renal replacement therapy (CRRT) with net ultrafiltration * Clinical stability considered sufficient to initiate net ultrafiltration according to the treating clinical team Exclusion Criteria: * Chronic kidney replacement therapy prior to ICU admission * Pregnancy * Limitation of therapeutic effort or goals-of-care decisions at admission or during the observation period * Inability to perform hemodynamic or perfusion assessment * Extracorporeal membrane oxygenation (ECMO) * Refusal to participate in the study

Primary outcome measure(s)

Trial sites (10)

FacilityCityRegionStatus
Hospital Cárdio Pulmonar Salvador Brazil Not Yet Recruiting
Hospital Clínico Regional de Concepción Concepción Chile Not Yet Recruiting
Complejo Asistencial Dr. Victor Ríos Ruiz Los Ángeles Chile Not Yet Recruiting
Hospital Clínico Dra. Eloísa Díaz Insunza de La Florida Santiago Chile Not Yet Recruiting
Hospital Las Higueras de Talcahuano Talcahuano Chile Recruiting
Hospital Universitario San José de Popayán Popayán Colombia Recruiting
Hospital General Enrique Garces Quito Ecuador Not Yet Recruiting
Ospedale San Bortolo Vicenza Italy Not Yet Recruiting
Hospital General de Mexico Mexico City Mexico Recruiting
Hospital Nacional Cayetano Heredia Lima Peru Not Yet Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07643597 on ClinicalTrials.gov ↗ ← All trials in Brazil